cancer

envie a um amigo share this

Developmental Pathways and Cancer: Wnt, Notch and Hedgehog

Fairmont Banff Springs, Banff, Alberta, Canada

 

2 - 7 February, 2014
 

 

Role of SPARC in bone remodeling and cancer-related bone metastasis

Considerable attempts have been made to produce adequate matrices or scaffolds that mimic bone ECM for applications in tissue engineering and regenerative medicine. In this context, several factors must be considered, such as the modification of biomaterial surfaces using growth factors, living bone cells or proteins, to guide cellular responses in bone remodeling, like osteoblast adhesion and long term functionality expressed as proliferation, synthesis of alkaline phosphatase and deposition of calcium containing mineral.

Role of SPARC in bone remodeling and cancer-related bone metastasis

Considerable attempts have been made to produce adequate matrices or scaffolds that mimic bone ECM for applications in tissue engineering and regenerative medicine. In this context, several factors must be considered, such as the modification of biomaterial surfaces using growth factors, living bone cells or proteins, to guide cellular responses in bone remodeling, like osteoblast adhesion and long term functionality expressed as proliferation, synthesis of alkaline phosphatase and deposition of calcium containing mineral.

MEX-3 proteins: recent insights on novel post-transcriptional regulators


Bruno Pereira (1), Mailys Le Borgne (2), Nicolas T. Chartier (2), Marc Billaud (2), and Raquel Almeida (1,3)

(1) IPATIMUP – Institute of Molecular Pathology and Immunology of the University of Porto, 4200-465 Porto, Portugal;

(2) INSERM-UJF U823, BP 170, 38042 Grenoble Cedex 9, France;

MEX-3 proteins: recent insights on novel post-transcriptional regulators

Uma proporção significativa de regulação genética é de natureza pós-transcricional, actuando ao nível do processamento, localização, tradução e degradação do ARN. A alteração nos níveis de expressão e/ou actividade das proteínas de ligação ao ARN, factores-chave envolvidos nestes processos de controlo, encontra-se subjacente a diversas patologias, incluindo no cancro.

Discovery of mutational signatures in the 30 more common cancer types

An international team of investigators, including Portuguese scientists Carlos Caldas and Samuel Aparício identified, by studying the genome of 7000 patients, more than 20 mutational signatures that lead to the 30 more common cancer types. This study was published in Nature and contains information that will help to understand cancer aetiology and development and also to improve prevention and treatment strategies.

Descobertas «assinaturas» mutacionais nos 30 cancros mais comuns

Uma equipa internacional de investigadores, que inclui os portugueses Carlos Caldas e Samuel Aparício, identificou, mediante o estudo do genoma de cerca de sete mil doentes, mais de 20 assinaturas mutacionais que conduzem ao aparecimento dos 30 tipos de cancro mais comuns. Este estudo foi publicado pela revista Nature e contém informação que ajudará a compreender a etiologia e o desenvolvimento do cancro e a melhorar a sua prevenção e tratamento.

Proteomic Forum 2013

17 - 21 March 2013

Berlin, Germany 
 
See more informations here: http://www.proteomic-forum.de/
 

Proteomic Forum 2013

 

17 - 21 March 2013
Berlin, Germany 
 
See more informations here: http://www.proteomic-forum.de/
 

Joint International Oncology (Sentinel Node and Cancer Metastasis) Congress

27 - 29 May 2013

San Francisco, California

 

See more informations here: http://www.sn-cancermets.org/